Adipose Derived Stem Cell Therapy Market Size Share Trends Forecast 2026


Posted July 26, 2021 by SANJAYCMI

“Coherent Market Insights “ADIPOSE DERIVED STEM CELL THERAPY MARKET – GLOBAL TRENDS, ESTIMATES AND FORECASTS, 2020-2027″
 
Adipose Derived Stem Cell Therapy Market Regional Analysis

North America is expected to hold a dominant position in the global Adipose Derived Stem Cell Therapy Market and account the largest market share during the forecast period, owing to high presence of key players in the region, which are engaged in research & development activities and implementing in-organic growth strategies such as acquisition and collaboration to increase its market presence.

For instance, in December 2017, Mesoblast Limited made exclusive license agreement with TiGenix NV, through which Mesoblast granted TiGenix an exclusive access to certain of its patents to support global commercialization of Cx601, adipose derived mesenchymal stem cell product, for the local treatment of fistulae.

Adipose derived stem cells (ADSCs) are stem cells derived from adipocytes, and can differentiate into variety of cell types. ADSCs have multipotency similar to bone marrow mesenchymal stem cells, thus ADSCs substitute for bone marrow as a source of stem cells. Numerous manual and automatic stem cell separation procedures are adopted in order to separate adipose stem cells (ASCs) from adipose tissue. Flow cytometry can also be used to isolate ADSCs from other stem cells within a cell solution.

Adipose derived stem cells are gaining appeal as a new cell source in regenerative medicine therapies as it can be differentiated into a variety of different cell lineages. These stem cells also have anti-apoptotic, anti-inflammatory, pro-angiogenic, immunomodulatory, and anti-scarring properties, which enhances its effectiveness.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2357

Adipose Derived Stem Cell Therapy Market Drivers

High effectiveness of adipose derived stem cell therapy in various medical and biotechnology research fields coupled with growing research and development activities by various research organizations is expected to boost the adoption of adipose-derived stem cell therapy in the market during the forecast period. Adipose derived stem cells (ADSCs) have various applications in medical and biomedical science field such as treatment of diabetes; regeneration of tissues partially in osteogenic, adipogenic, chondrogenic, and cardiovascular areas of medicine; bone regeneration; fat reconstruction; and myocardial and cardiovascular regeneration; among others.

For instance, in November 2018, a peer-reviewed case study conducted using a stem cell processed by Celltex Therapeutics Corporation, showed the improvement in disease findings following systemic administration of autologous adipose derived mesenchymal stem cells (MSCs).

Adipose Derived Stem Cell Therapy Market Restraint

High cost associated with stem cell processing, need of skilled professional for managing, preserving, and scale-up of stem cell lines are the limiting factors, which are expected to restrain the growth of the adipose derived stem cell therapy market during the forecast period.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/adipose-derived-stem-cell-therapy-market-2357

For instance, Bioinformant— a research firm engaged in stem cell research— released a data on November 2018, on cost of stem cell therapy and various key factors impacting the cost of stem cell therapy including types of stem cells used within procedure, number of treatment, and the site of the clinic. The study findings reveal the cost of stem cell therapy ranges between US$ 5,000-8,000 per patient, in some cases it may rise as much as US$ 25,000 or more depending on the complexity of the procedure.

Adipose Derived Stem Cell Therapy Market Key Players

Key players operating in the global adipose derived stem cell therapy market include BioRestorative Therapies, Inc., Celltex Therapeutics Corporation, Antria, Inc., Cytori Therapeutics Inc., Intrexon Corporation, Mesoblast Ltd., iXCells Biotechnologies, Pluristem Therapeutics, Inc., Thermo Fisher Scientific, Inc., Tissue Genesis, Inc., Cyagen US Inc., Celprogen, Inc., and Lonza Group, among others.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2357

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Coherent Market Insights
Phone +1-206-701-6702
Business Address 1001 4th Ave
# 3200 Seattle, WA 98154, U.S.
Country United States
Categories Health , Marketing , Research
Tags adipose derived stem cell therapy , adipose derived stem cell therapy market growth , adipose derived stem cell therapy market research
Last Updated July 26, 2021